CCR5 and infection: All of these and the successful curative impact seen from Δ32 mutation hematopoietic stem cell transplantation into the Berlin patient with AIDS and leukemia [36] have given additional impetus towards the use of CCR5 targeting drugs to combat HIV-1 entry and infection.